CLINICAL_TRIALS
withdrawal
· 2017-03-03
Clinical Trial Update: Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases [Phase 4]
Summary
A Phase 4 clinical trial comparing radiofrequency ablation plus chemotherapy versus chemotherapy alone for patients with secondary liver cancer has been withdra…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Metastatic Liver Cancer, Secondary Liver Cancer | Phase 4 | Status: WITHDRAWN